Crucell, Harvard's Adenoviral Vector Work Gets $19M Grant Aug. 2, 2005 By Jennifer Boggs Crucell NV's ongoing collaboration with Harvard Medical School to develop vaccine technology using adenovirus-based vectors received a $19.2 million boost from the National Institutes of Health. (BioWorld Today)Read More
